| Bioactivity | HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1]. |
| Name | HBV-IN-16 |
| CAS | 2355225-38-4 |
| Formula | C22H20ClNO4 |
| Molar Mass | 397.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1. |
HBV-IN-16
CAS: 2355225-38-4 F: C22H20ClNO4 W: 397.85
HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.